[ Price : $8.95]
FDA approves Bristol Myers Squibbs Opdivo Qvantig subcutaneous injection for several cancer indications.[ Price : $8.95]
FDA approves Checkpoint Therapeutics Unloxcyt to treat some squamous cell cancer patients.[ Price : $8.95]
FDA approves Xcoverys Ensacove, an anaplastic lymphoma kinase inhibitor, to treat some non-small cell lung cancers.[ Price : $8.95]
FDA approves Humacytes Symvess for use with some extremity arterial injuries.[ Price : $8.95]
FDA alerts patients, caregivers, and healthcare providers to the potential for some Boston Scientific Accolade pacemakers to need ...[ Price : $8.95]
Axsome Therapeutics plans an NDA submission for AXS-05 (dextromethorphan-bupropion) in the second half of next year for treating A...[ Price : $8.95]
Novo Nordisk petitions FDA to exclude its liraglutide from the agencys list of bulk drug substances that may be used by drug compo...[ Price : $8.95]
FDA posts a six-item Form FDA-483 that led to a 12/19 Warning Letter to Mylan Laboratories citing its Pradesh, India manufacturing...